You are here

Gebelik ve tanısal radyasyon

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
X-ray exposures in pregnancy and influence on fetus are the least known and one of the most difficult subject to be researched. Especially, to decide radiation exposure of pregnant for diagnosis and treatmentEproposes requireEa serious decision mechanism. Researches showed that the dose may be harmful to fetus is 5 rad (50 mGy), and if the fetus is exposued under this amount, the possibility to be harmful is quite low. 50 mGy is such a high dose which can not to be gained by any radiological examination.
Abstract (Original Language): 
Gebelikte maruz kalınan X ışını etkileri ve fetal etkilenim en az bilinen, araştırılması zor konulardan biridir. Özellikle gebenin, tanı ve tedavi amaçlı radyasyon maruziyetine karar vermek ciddi bir karar mekanizması gerektirmektedir. Yapılan araştırmalar fetusa zararlı olabilecek radyasyon dozunun 5 rad (50mGy) olduğunu, fetusun bu miktarın altında radyasyona maruz kalması durumuda ise zarar görme olasılığının son derece uzak olduğunu ortaya koymuştur. 50 mGy tanısal amaçlı kullanılan hiçbir radyoloji tekniği ile ulaşılamayacak kadar yüksek bir dozdur.
182-185

REFERENCES

References: 

1. Ratnapalan S, Bona N, Chandra K, Koren G.Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am JRoentgenol2004; 182:1107- 1109.
2. Groves AM, Yates SJ, Win T, et al. CT pulmonary angiography versus ventilation-perfiision scintigraphy in pregnancy: implications from a UK survey ofdoctors' knowledge ofradiation exposure. Radiology 2006;
S.D.Ü. Tıp pak.
Derg
. 2012:19(1)/182-185
185
Löker Altıntaş, Gebelik ve tanısal radyasyon
240:765-770.
3. Brent RL, Mettler FA. Pregnancy policy. AJR Am J Roentgenol 2004;182:819-822.
4. Exposure of the Pregnant Patient to Diagnostic Radiations A Guide to Medical Management" Second Edition, by Louis K Wagner, Richard G. Lester, and Luis R. Saldana, 1997, Medical Physics Publishing, Madison, Wisconsin.
5. Wagner LK, Lester RG, Saldana LR. Exposure ofthe pregnant patient to diagnostic radiations: a guide to medical management. 2nd ed. Madison, Wis: Medical Physics, 1997.
6. International Commission on Radiological Protection. Biological effects after prenatal irradiation (embryo and fetus). CRP publication no. 90. New York, NY: Pergamon, 2003, 153-182.
7. Doll R, Wakeford R. Risk ofchildhood cancer from fetal irradiation. Br J Radiol 1997; 70:130- 139.
8.Oyar O. Radyasyon Fiziği. Tıbbi Görüntüleme Fiziği 2003; 24-28.
9. Baerga-Varela Y, Zietlow SP, Bannon MP, Harmsen WS, Ilstrup DM. Trauma in pregnancy. Mayo Clin Proc 2000; 75:1243-1248.
10. Grossman NB. Blunt trauma in pregnancy. Am Fam Physician2004; 70:1303-1310.
11. Scarsbrook AF, Evans AL, Owen AR, Gleeson FV. Diagnosis ofsuspected venous thromboembolic disease in pregnancy. Clin Radiol 2006; 61: 1-12.
12. Schuster ME, Fishman JE, Copeland JF, Hatabu H, Boiselle PM. Pulmonary embolism in pregnant patients: a survey of practices and policies for CT pulmonary angiography. AJR Am J Roentgenol 2003;181:1495-1498.
13. International Commission on Radiological Protection. Recommendations ofthe International Commission on Radiological Protection 2007; 103,37.
14. International Commission on Radiological Protection. Doses to the embryo and fetus from intakes of radionuclides by the mother. ICRP Publication 2001; 31(1-3).
15. International Commission on Radiological Protection. Doses to infants from ingestion ofradionulcides in mothers' milk ICRP Publication 2004; 34 (3-4).

Thank you for copying data from http://www.arastirmax.com